ADvantage Therapeutics
Operator of a pharmaceutical company intended to develop therapeutics for patients suffering from neurodegenerative disease. The company specializes in developing therapies to treat Alzheimer's Diseas...
Valuation
$81M
Market implied
Share Price
N/A
Total Raised
$18.7M
Last Round
N/A